Zanjani E D, Srour E F, Hoffman R
Department of Veterans Affairs Medical Center, Reno, NV 89520, USA.
J Lab Clin Med. 1995 Jul;126(1):24-8.
We have previously reported on the successful engraftment and long-term multilineage expression (erythroid, myeloid, lymphoid) of human adult marrow CD34+ HLA-DR- cells in sheep after transplantation in utero. The persistence in these animals of CD34+ HLA-DR- cells, the phenotype of the original graft, and the presence of assayable high proliferative potential colony-forming cells (HPP-CFCs), a primitive progenitor cell that has self-renewal capacity and multilineage differentiative capacity, suggested that these chimeric animals continued to contain human pluripotent hematopoietic stem cells (HSCs). To test this hypothesis, CD45+ cells from the bone marrow of such an animal were isolated by panning at 19 and 24 months after birth, were pooled, and were transplanted into 4 preimmune sheep fetuses (0.6 x 10(6) viable cells per fetus). Three of the sheep were born alive. Bone marrow from one of these secondary recipients (lamb 58) exhibited significant donor (human) cell presence at 3, 9, 12, and 15 months (last evaluation period) after transplant. The engraftment was sustained along with multilineage expression involving lymphoid, erythroid, and myeloid cells of human origin. These results indicated that human CD34+ HLA-DR- cells are capable of long-term marrow repopulation and that this cell population is enriched for human long-term repopulating HSCs.
我们之前曾报道,人成人骨髓CD34+HLA-DR-细胞在子宫内移植到绵羊体内后成功植入并长期进行多系表达(红细胞系、髓细胞系、淋巴细胞系)。这些动物体内CD34+HLA-DR-细胞(原始移植物的表型)持续存在,且存在可检测到的高增殖潜能集落形成细胞(HPP-CFC),这是一种具有自我更新能力和多系分化能力的原始祖细胞,提示这些嵌合动物体内持续存在人多能造血干细胞(HSC)。为验证这一假设,在出生后19个月和24个月通过淘选从一只此类动物的骨髓中分离出CD45+细胞,将其汇集后移植到4只未免疫的绵羊胎儿体内(每只胎儿移植0.6×10⁶个活细胞)。其中3只绵羊存活出生。其中一名二次受体(羔羊58)在移植后3、9、12和15个月(最后评估期)骨髓中显示出显著的供体(人)细胞存在。植入持续存在,同时涉及人源淋巴细胞系、红细胞系和髓细胞系的多系表达。这些结果表明,人CD34+HLA-DR-细胞能够长期重建骨髓,并且该细胞群体富含人长期重建HSC。